by EBSCO Medical Review Board

Metabolic syndrome is a group of risk factors. Some medicines can be used to treat metabolic syndrome. They are used if other treatments do not work.

Blood pressure may be treated with:

  • Diuretics
  • Angiotensin converting enzyme inhibitors
  • Beta blockers
  • Calcium channel blockers
  • Vasodilators

Blood glucose may be treated with:

  • Insulin
  • Sulfonylurea
  • GLP-1 receptor agonists
  • SGLT2 inhibitors
  • Metformin
  • Glitazones
  • Alpha-glucosidase inhibitors
  • Orlistat
  • Pramlintidine
  • DPP-4 inhibitors

Triglycerides may be treated with:

  • Statins
  • Fibrates
  • Niacin
  • Omega-3 fatty acids

Obesity may be treated with:

  • Orlistat
  • Bupropion-naltrexone
  • Liraglutide
  • Phentermine-topiramate

High cholesterol may be treated with:

  • Simvastatin
  • Atorvastatin
  • Fluvastatin
  • Lovastatin
  • Pitavastatin
  • Pravastatin
  • Rosuvastatin

References

Hypertension. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/hypertension . Accessed April 12, 2022.

Hypertriglyceridemia. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/hypertriglyceridemia. Accessed April 12, 2022.

Metabolic syndrome. Merck Manual Professional Version website. Available at: https://www.merckmanuals.com/professional/nutritional-disorders/obesity-and-the-metabolic-syndrome/metabolic-syndrome. April 12, 2022.

Metabolic syndrome. National Heart, Lung, and Blood Institute website. Available at: https://www.nhlbi.nih.gov/health-topics/metabolic-syndrome. Accessed April 12, 2022.

Metabolic syndrome in adults. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/metabolic-syndrome-in-adults . Accessed April 12, 2022.

Prevention and treatment of metabolic syndrome. American Heart Association website. Available at: https://www.heart.org/en/health-topics/metabolic-syndrome/prevention-and-treatment-of-metabolic-syndrome. Accessed April 12, 2022

Sherling DH, Perumareddi P, et al. Metabolic Syndrome. J Cardiovasc Pharmacol Ther. 2017;22(4):365-367.

Revision Information